Osteoradionecrosis in head-and-neck cancer has a distinct genotype-dependent cause.
West, Catharine M L
Slevin, Nicholas J
AffiliationHead and Neck Unit, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK. Andrew.Lyons@gstt.nhs.uk
MetadataShow full item record
AbstractWe performed a case-control study to establish whether the development of osteoradionecrosis (ORN) was related to a variant allele substituting T for C at -509 of the transforming growth factor-β1 gene (TGF-β1).
CitationOsteoradionecrosis in head-and-neck cancer has a distinct genotype-dependent cause. 2012, 82 (4):1479-84 Int J Radiat Oncol Biol Phys
JournalInternational Journal of Radiation Oncology, Biology, Physics
- Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
- Authors: Brezzi B, Del Prete D, Lupo A, Magistroni R, Gomez-Lira M, Bernich P, Anglani F, Mezzabotta F, Turco A, Furci L, Ceol M, Antonucci F, Abaterusso C, Bonfante L, D'Angelo A, Albertazzi A, Gambaro G
- Issue date: 2009 Nov-Dec
- Analysis of microvascular free flaps for reconstruction of advanced mandibular osteoradionecrosis: a retrospective cohort study.
- Authors: Hirsch DL, Bell RB, Dierks EJ, Potter JK, Potter BE
- Issue date: 2008 Dec
- Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.
- Authors: Guo W, Dong Z, Guo Y, Chen Z, Yang Z, Kuang G, Shan B
- Issue date: 2011 Jun
- Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer.
- Authors: Lundberg M, Pajusto M, Koskinen WJ, Mäkitie AA, Aaltonen LM, Mattila PS
- Issue date: 2009 May
- The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
- Authors: Eliopoulos DG, Mavroudi I, Pontikoglou C, Ximeri M, Stavroulaki E, Pyrovolaki K, Velegraki M, Spanoudakis M, Goulielmos G, Papadaki HA
- Issue date: 2009 Dec 1